Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,994
Closed -$415K 1633
2022
Q1
$415K Sell
7,994
-20,308
-72% -$1.05M 0.01% 914
2021
Q4
$1.67M Buy
28,302
+13,017
+85% +$746K 0.02% 503
2021
Q3
$837K Buy
15,285
+4,258
+39% +$237K 0.02% 392
2021
Q2
$565K Sell
11,027
-4,739
-30% -$245K 0.01% 944
2021
Q1
$814K Buy
15,766
+4,398
+39% +$242K 0.02% 809
2020
Q4
$638K Sell
11,368
-907
-7% -$48.4K 0.02% 775
2020
Q3
$681K Sell
12,275
-62,655
-84% -$3.25M 0.02% 967
2020
Q2
$3.4M Buy
+74,930
New +$3.35M 0.06% 432
2020
Q1
Sell
-53,711
Closed -$1.93M 1913
2019
Q4
$1.93M Buy
53,711
+40,791
+316% +$1.52M 0.03% 607
2019
Q3
$452K Buy
+12,920
New +$497K 0.01% 1235
2018
Q4
Sell
-8,077
Closed -$325K 1688
2018
Q3
$325K Buy
8,077
+2,676
+50% +$107K 0.01% 1197
2018
Q2
$207K Sell
5,401
-6,148
-53% -$226K ﹤0.01% 1460
2018
Q1
$395K Buy
+11,549
New +$406K 0.01% 1499
2017
Q3
Sell
-37,710
Closed -$1.34M 2364
2017
Q2
$1.34M Buy
+37,710
New +$1.27M 0.02% 1027

Other funds holding QGEN

Paloma Partners's QGEN Position: Q2 2022 in Review

Paloma Partners sold out of Qiagen (QGEN) in Q2 2022, closing a stake of 7,994 shares — an estimated $415K sold.

Paloma Partners first reported a position in QGEN in Q2 2017 and held it in 14 quarters. The position peaked at $3.4M in Q2 2020. 287 funds tracked by Wall St. Rank hold QGEN as of Q2 2022.

  • Paloma Partners reported no remaining Qiagen position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 7,994 Qiagen shares in Q2 2022, an estimated $415K.
  • Paloma Partners first reported a position in Qiagen in Q2 2017 and held it in 14 quarters.
  • Paloma Partners's Qiagen position peaked at $3.4M in Q2 2020.
  • 287 funds tracked by Wall St. Rank held Qiagen as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.